Before:

And After:



Starting and operating nuclear pharmacies.
Starting and managing specialty IV compounding pharmacies.
Cardioplegia solutions.
TPN Solutions
Intrathecal Pumps Medications
Pharmaceutical Repackaging
Pharmaceuticals industry
2010 – Present (1 year)
Meds IV, Inc is a pharmaceutical company focused in delivering complex compounded sterile products to hospitals and physician offices including intrathecal pump medication refills and schedule II epidural and PCA products.
TPN/Cardiopelgia/Anesthesia Syringes/Oxytocin
Pharmaceuticals industry
2010 – Present (1 year)
MedWorksRx develops and manages retail pharmacy operations.
Privately Held; Pharmaceuticals industry
January 2009 – Present (2 years 3 months)
Pharmaeutical Repackager
Pharmaceuticals industry
2005 – Present (6 years)
Nuclear Pharmacy Services
Pharmaceuticals industry
October 2009 – October 2010 (1 year 1 month)
President of the Alabama affiliate of ASHP
Pharmaceuticals industry
1999 – 2004 (5 years)
Lead the South East Region of Nuclear Pharmacy Services division of Cardinal Health.
1987 – 1990
ASHP, AlSHP, Birmingham Emmaus Community
2007 Birmingham Top 40 under 40
Advanced Specialty Pharmacy, LLC (ASP) today announced that litigation initiated by Cardinal Health 414, Inc. ("Cardinal") against ASP and related parties has been amicably resolved.The original lawsuit (Case No. 2006-CV-2305) was filed on April 28, 2006, in the United States District Court, Eastern District of Louisiana.
Advanced Specialty’s counter-claim filed in this litigation against Cardinal that asserted violations of various federal and state antitrust laws will also be dismissed as part of the settlement.
Although the terms of settlement are to remain confidential between the parties, Advanced Specialty Pharmacy will continue to serve its nuclear pharmacy customers in all of its existing markets. "ASP envisions rapid future growth in these markets based on our business model of very competitive pricing and a responsiveness to customer needs that large national companies cannot match," stated Tim Rogers, a co-founder of ASP.
We will be looking into the initial claim by Cardinal against Advanced Specialty Pharmacy but take a look at the timing of it: This dismissal is from October 2006, the initial claim probably some time in 2005. Tim Rogers worked at Cardinal until 2004 and co-founded Advanced Specialty Pharmacy in 2005. We're thinking the litigation may have been regarding Tim Rogers violating a non-compete clause he had with Cardinal, especially since his counter suit asserted that Cardinal violated antitrust laws.
The Alabama Department of Public Health said it first learned of the problem on March 16, when two hospitals in the state notified officials of patients with bloodstream infections.This event will no doubt raise questions about quality control at compounding pharmacies. Unlike most pharmacies, compounding pharmacies make most of the solutions they dispense themselves. This provides a value for patients that require custom made ointments, oral solutions, and IVs. But it does make it more difficult to ensure the dosage and quality. Instead of mass producing thousands of the same pill on a daily basis as a pharmaceutical manufacturer might do which could be more easily monitored and controlled, compounding pharmacies produce their medications only when a particular patient has a need for it. They're made to order. So one minute a pharmacist is making an oral solution, the next minute the same pharmacist could be producing a completely different inhalant powder.
The cases of bacteremia were caused by Serratia marcescens, a germ that produces bright bright red colonies. The bacterium was identified and named in Italy in the early 1800s, after it was found to be turning polenta blood-red.




Compounding & The Hard-To-Find Market
Parenteral Nutrition Product Shortages
There is a growing and critical shortage of electrolyte and mineral injections needed for parenteral nutrition. We have heard from many consumer groups, healthcare systems, and clinicians regarding their short supplies or inability to obtain these products. The seriousness of this shortage has the potential to be similar to that of intravenous (IV) multivitamins, which resulted in significant complications and some deaths.